Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTDC1 antisense RNA 1 (QTMAN-AS1 or GTDC1-AS1) is a long non-coding RNA transcribed from the antisense strand of the GTDC1 gene locus. While GTDC1 is a protein coding gene involved in tRNA mannosylation and regulation of translation[1][3], QTMAN-AS1 itself is classified as a lncRNA, with no documented protein product, functional roles, disease associations, or therapeutic targeting[5][7]. Current databases offer only basic gene mapping and classification details, without further evidence regarding its specific molecular mechanism or biological impact. Therefore, QTMAN-AS1 is primarily annotated as an antisense RNA without known clinical or biological roles at this time[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTDC1 antisense RNA 1 (QTMAN-AS1).